← Leaderboards
Michael S Wolin
New York Medical College
$11,334,350
Attributed
$12,974,350
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$12,974,350 · 7
By mechanism
R01$8,937,625 · 5
P01$2,731,887 · 1
R37$1,304,838 · 1
Top collaborators
- Brian Blake Ratliff4 shared
- Dong Sun4 shared
Most similar at New York Medical College
Same institution · by research overlap
- Nader G Abraham$10,346,121
- Michal Laniado Schwartzman$18,004,835
- Brian Blake Ratliff$820,000
- Sachin A Gupte$4,159,124
- Joseph M Miano$20,018,004
Others in their field
Top investigators on “Nitric Oxide”
- Solomon H Snyder · Johns Hopkins University$33,003,131
- Jay Louis Zweier · Ohio State University$27,671,715
- Stuart A Lipton · Burnham Institute For Medical Research$26,301,120
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$24,661,240
- Jonathan S. Stamler · Case Western Reserve University$24,571,968
- William C. Sessa · Yale University$21,022,028
Research focus
Nitric OxideBlood VesselsCoronary ArteryGenerationsRegulationMediatingTissuesSignal TransductionOxidation-ReductionArteriesSuperoxidesCyclic GmpOxidationVascular Smooth MuscleOxidantsHydrogen PeroxideGlutathioneNadpMetabolicEndotheliumPathway InteractionsOxidasesProductionCattle
Grant awards (43)
NOX4-associated oxidative stress mediates vascular and kidney impairment in the low birth weight adult$410,000
R01 · FY2023 · HL
NOX4-associated oxidative stress mediates vascular and kidney impairment in the low birth weight adult$410,000
R01 · FY2022 · HL
NOX4-associated oxidative stress mediates vascular and kidney impairment in the low birth weight adult$410,000
R01 · FY2021 · HL
NOX4-associated oxidative stress mediates vascular and kidney impairment in the low birth weight adult$410,000
R01 · FY2020 · HL
Ferrochelatase & guanylate cyclase regulation in vascular dysfunction$410,000
R01 · FY2019 · HL · contact PI
Ferrochelatase & guanylate cyclase regulation in vascular dysfunction$410,000
R01 · FY2018 · HL · contact PI
Ferrochelatase & guanylate cyclase regulation in vascular dysfunction$410,000
R01 · FY2017 · HL · contact PI
Ferrochelatase & guanylate cyclase regulation in vascular dysfunction$410,000
R01 · FY2016 · HL · contact PI
ecSOD derived peroxide in pulmonary adaptation to hypoxia$402,500
R01 · FY2016 · HL · contact PI
ecSOD derived peroxide in pulmonary adaptation to hypoxia$396,462
R01 · FY2015 · HL · contact PI
ecSOD derived peroxide in pulmonary adaptation to hypoxia$394,450
R01 · FY2014 · HL · contact PI
ecSOD derived peroxide in pulmonary adaptation to hypoxia$383,180
R01 · FY2013 · HL · contact PI
Oxidants and Nitric Oxide in Coronary Vascular Function$372,109
P01 · FY2011 · HL · contact PI
Oxidants and Nitric Oxide in Coronary Vascular Function$372,109
P01 · FY2010 · HL · contact PI
Reactive Oxygen Species and Vascular O2 Sensing$302,952
R01 · FY2010 · HL · contact PI
Pulmonary Vasodilation and Guanylate Cyclase Regulation$278,250
R01 · FY2010 · HL · contact PI
Oxidants and Nitric Oxide in Coronary Vascular Function$372,109
P01 · FY2009 · HL · contact PI
Reactive Oxygen Species and Vascular O2 Sensing$302,952
R01 · FY2009 · HL · contact PI
Pulmonary Vasodilation and Guanylate Cyclase Regulation$278,250
R01 · FY2009 · HL · contact PI
Pulmonary Vasodilation and Guanylate Cyclase Regulation$428,625
R01 · FY2008 · HL · contact PI
Oxidants and Nitric Oxide in Coronary Vascular Function$364,093
P01 · FY2008 · HL · contact PI
Reactive Oxygen Species and Vascular O2 Sensing$302,952
R01 · FY2008 · HL · contact PI
Oxidants and Nitric Oxide in Coronary Vascular Function$369,769
P01 · FY2007 · HL · contact PI
Reactive Oxygen Species and Vascular O2 Sensing$302,952
R01 · FY2007 · HL · contact PI
Pulmonary Vasodilation and Guanylate Cyclase Regulation$276,500
R01 · FY2007 · HL · contact PI
Pulmonary Vasodilation and Guanylate Cyclase Regulation$150,100
R01 · FY2007 · HL · contact PI
Reactive Oxygen Species and Vascular O2 Sensing$362,000
R01 · FY2006 · HL · contact PI
OXIDANTS AND NITRIC OXIDE IN CORONARY VASCULAR FUNCTION$247,247
P01 · FY2005 · HL
PULMONARY VASODILATION AND GUANYLATE CYCLASE REGULATION$234,750
R37 · FY2005 · HL
OXIDANTS AND NITRIC OXIDE IN CORONARY VASCULAR FUNCTION$240,046
P01 · FY2004 · HL
PULMONARY VASODILATION AND GUANYLATE CYCLASE REGULATION$234,750
R37 · FY2004 · HL
REACTIVE OXYGEN SPECIES AND VASCULAR O2 SENSING$273,875
R01 · FY2003 · HL
PULMONARY VASODILATION AND GUANYLATE CYCLASE REGULATION$234,750
R37 · FY2003 · HL
REACTIVE OXYGEN SPECIES AND VASCULAR O2 SENSING$273,875
R01 · FY2002 · HL
PULMONARY VASODILATION AND GUANYLATE CYCLASE REGULATION$195,625
R37 · FY2002 · HL
OXIDANTS AND NITRIC OXIDE IN CORONARY VASCULAR FUNCTION$0
P01 · FY2002 · HL
OXIDANTS AND NITRIC OXIDE IN CORONARY VASCULAR FUNCTION$0
P01 · FY2002 · HL
REACTIVE OXYGEN SPECIES AND VASCULAR O2 SENSING$273,875
R01 · FY2001 · HL
PULMONARY VASODILATION AND GUANYLATE CYCLASE REGULATION$222,320
R37 · FY2001 · HL
OXIDANTS AND NITRIC OXIDE IN CORONARY VASCULAR FUNCTION$0
P01 · FY2001 · HL
OXIDANTS AND NITRIC OXIDE IN CORONARY VASCULAR FUNCTION$394,405
P01 · FY2000 · HL
REACTIVE OXYGEN SPECIES AND VASCULAR O2 SENSING$273,875
R01 · FY2000 · HL
VASODILATION AND GUANYLATE CYCLASE REGULATION$182,643
R37 · FY2000 · HL